Israeli drugmaker Teva Pharmaceutical Industries Ltd on Monday announced it would acquire rival pharma company Cephalon for $6.8 billion in cash.
Teva will pay $81.50 for CEPH.q, which marks a 6% upside from the stock’s Friday closing price of $77.02. The deal is expected to close in the third quarter.
http://www.tevapharm.com/Teva will pay $81.50 for CEPH.q, which marks a 6% upside from the stock’s Friday closing price of $77.02. The deal is expected to close in the third quarter.
Aucun commentaire:
Enregistrer un commentaire